Mania and hypomania

• A possible association between creativity and schizotypy in bipolar illness
• Abnormal semantic processing in bipolar manic patients: preliminary study
• Activation of signal pathways related to protein translation initiation in the brain of ouabain rat model of mania
• Altered white matter connectivity and water diffusivity in bipolar I and II disorder: a diffusion tensor imaging study
• An investigation of the relationship between childhood trauma and the 12-month outcome of first episode mania in adolescents and young adults
• Antipsychotics in the treatment of hospitalized manic patients in Turkey: retrospective naturalistic one year data
• Asenapine in bipolar disorder: an overview of clinical trials in the olympia program
• Association analysis of adenosine A1 receptor (ADORA1) and dopamine D1 receptor (DRD1) genes with Bipolar Disorder and schizophrenia in the Japanese population
• BDNF levels in the rat prefrontal cortex, amygdala and hippocampal CA3 region in an animal model of mania
• Biomarkers of oxidative stress in schizophrenic and bipolar patients during manic episode
• Bipolar II Disorder: is it discrete from Bipolar I Disorder?
• Brain dysfunction in schizomanic patients versus healthy controls: a fMRI study
• Brazilian validation of the HCL-32-R1 (the Hypomania Checklist, first revision)
• Caregiver depression and youth report of depression and mania symptoms predict family functioning
• Cognitive assessment in a crack users population with and without mood disorders: a pilot study
• Comparative study of personality traits in patients with bipolar I and II disorder from the five-factor model perspective
• Comparison between clinical characteristics of suicide attempters and non-attempters in a sample of bipolar disorder patients with mania as first episode polarity
• Comparison of creatine kinase levels in depressed, manic and euthymic patients with bipolar disorder
• Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder
• Complement system in bipolar disorders and schizophrenia: C3 and C4
• Correlation between serum brain-derived neurotrophic factor and neurotrophin-3 levels in bipolar disorder
• Cyclic alternating pattern during sleep in patients with bipolar diosrders
• Decreased cellular viability in SH-SY5Y neuroblastoma cell line induced by incubation with serum from manic bipolar patients
• Early life stress does not alter global DNA methylation in the striatum of an animal model of mania
• Effect of acute administration of fenproporex on mitochondrial respiratory chain in the brain of adult rats
• Effect of mood stabilizers on behavioral and manic-like symptoms secondary to herpes simplex encephalitis: a case report
• Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain
• Effects of sodium butyrate and tamoxifen on creatine kinase activity in an animal model of mania
• Electroconvulsive therapy in the treatment of hospitalized manic patients in turkey: retrospective naturalistic one year data
• Factors affecting weight in subjects with an episode of mania in the first month of treatment
• Functional impairment and disability across mood states in subjects with bipolar disorder
• Increased plasma levels of chemokines in bipolar disorder patients in mania
• Increased plasma levels of soluble TNF-alpha receptors in bipolar disorder patients
• Increased risk of hypomanic symptoms during puerperium: a population survey
• Insight and cognitive functions in subjects with bipolarity I
• Interfering with the activating effect of calbindin D28k on inositol monophosphatase activity
• Mania in a man treated with modafinil
• Mass spectrometry of synaptosome after treatment with m-amphetamine as a potential means to investigate the pathophysiology of bipolar disorder
• Metabolic syndrome and associated risk factors in maintenance treatment of bipolar disorder with ziprasidone adjunctive therapy
• Mitochondrial respiratory chain activity in an animal model mania induced by ouabain
• Multimodal measurement of impulsivity in adolescents with Bipolar Disorder versus adolescents with ADHD
• Na-K ATPase dysfunction in Bipolar Disorder: application of ouabain rat model of bipolar disorder
• Orbitofrontal dysfunction during reward and punishment anticipation in mania
• Oxidative parameters in brain of wistar rats in an animal model of mania induced by ouabain
• Prevalence and disability of DSM-IV bipolar disorder in Korean general population survey
• Psychiatric hospitalizations due to bipolar disorder, major depression disorder and schizophrenia in Rio Grande do Sul, Brazil
• Psychotic symptoms and brain volumes in first episode patients with bipolar disorder: is there a connection? data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)
• Resource utilization and cost estimation in first manic episode in bipolar disorders: follow-up from the first episode to the next relapse
• Results of a double-blind, randomized, dose-titration, placebo controlled multicenter trial (SCO/BIA-2093-203 study) on safety and efficacy of eslicarbazepine acetate (BIA 2-093) for acute manic episodes associated with biopolar I disorder
• Serum levels of proinflammatory and anti-inflamatory cytokines in acute mania and schizophrenia: differences in pro and anti-inflamatory balance
• Serum thiobarbituric acid reactive substances in bipolar disorder during mania and schizophrenia: a biomarker with possible diagnostic implications
• The EPPIC 800 study: the longer-term clinical and functional outcome of 93 individuals with first episode bipolar disorder
• The use of mood stabilizers in acute manic patients in Turkey
• The Val66Met polymorphism and bipolar disorder in a Mexican sample
• Treatment outcomes based on disease severity for subjects with bipolar I disorder treated with ziprasidone plus a mood stabilizer
• Twelve-month prevalence and impact of DSM-IV bipolar disorder in an Australian general population survey
• Valnoctamide as a valproate substitute with low teratogenic potential in mania: double-blind controlled clinical trial

57 abstracts